U.S. market Closed. Opens in 7 hours 38 minutes

GANX | Gain Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue55.18K140.11K164.99K28.88K41.30K20.61K
Cost of Revenue80.38K64.17K7.16M2.26MN/AN/A
Gross Profit-25.20K75.94K-7.00M-2.23M41.30K20.61K
Operating Expenses22.23M17.92M13.99M3.51M2.14M1.05M
Selling, General & Admin10.74M9.54M6.83M1.25M555.16K222.05K
Research & Development11.49M8.38M7.16M2.26M1.59M826.88K
Other Operating Expenses-12.13MN/AN/AN/AN/AN/A
Operating Income-22.25M-17.78M-13.83M-3.48M-2.10M-1.03M
Other Expenses / Income64.89K279.28K-60.42K-92.85K-86.22K-14.96K
Before Tax Income-22.19M-17.50M-13.89M-3.57M-2.19M-1.10M
Income Tax Expenses79.28K92.98K4.01K5.39K7.11K9.78K
Net Income-22.27M-17.59M-13.89M-3.58M-2.19M-1.11M
Interest ExpensesN/A-247.38KN/AN/A20.54KN/A
Basic Shares Outstanding13.01M11.88M10.17M11.88M11.88M5.86M
Diluted Shares Outstanding13.01M11.88M10.17M11.88M11.88M5.86M
EBITDA-22.17M-17.68M-13.75M-3.37M-2.03M-1.01M
EBITDA Margin-40,182.58%-12,619.53%-8,335.61%-11,680.25%-4,919.63%-4,913.45%
EBIT-22.19M-17.75M-13.89M-3.57M-2.17M-1.10M
EBIT Margin-40,210.67%-12,665.33%-8,416.43%-12,369.02%-5,243.92%-5,316.90%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙